TROG Cancer Research
Members Login   CQMS Login

TROG 03.01

Primary sponsor: TROG
Collaborating group: NCI CTG (ES 2)


An advanced oesophageal cancer study to compare quality of life and palliation of dysphagia


People with cancer of the oesophagus (gullet) often have trouble swallowing. Radiotherapy can help improve this problem. Using chemotherapy together with radiotherapy may work better but has more side effects. This trial will determine if it is better to use radiotherapy by itself or together with chemotherapy.

Final accrual

International: 220
TROG: 116

Trial Status

Closed to follow-up, June 2013

Trial chairperson

Dr Michael Penniment, Royal Adelaide Hospital, SA

Trial contact

Ms Sonya Stephens
Royal Adelaide Hospital
Phone: +61 8 8222 4042

Further information

TROG 03.01 on Australian Cancer Trials website

Trial resources for TROG members

TROG 03.01 member page

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.